Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A major international study published today in BMJ Public Health has found that a digitally enabled healthcare programme was associated with significant improvements in blood pressure control among people living with hypertension across sub-Saharan Africa.

Two African health professionals, female and male, discussing while working with a laptop.

The study analysed routinely collected data from more than 63,000 patients receiving care at 246 health facilities in Ghana, Kenya, Sierra Leone and Tanzania between 2019 and 2024. The programme combined mobile technology, local clinics and training for community health workers to support blood pressure monitoring, follow-up care, and health education for people living with long-term conditions.

Researchers from the Nuffield Department of Primary Care Health Sciences, Ministries of Health, faith-based and academic partners across Ghana, Kenya, Sierra Leone, and Tanzania, and Medtronic LABS found that patients' blood pressure improved substantially within six months of joining the programme.

Average systolic blood pressure - the top number in a reading, which shows the pressure when the heart beats - fell by 8.3 mmHg, while average diastolic blood pressure - the bottom number, which shows pressure when the heart is at rest - fell by 4.5 mmHg. The largest improvements were seen among patients who entered the programme with uncontrolled systolic blood pressure, with average reduction of 18.1 mmHg.

The proportion of patients with controlled blood pressure rose from 35% to 53%, while just over half, 52.9%, achieved a clinically meaningful reduction in systolic blood pressure of more than 5 mmHg. Patients who had more frequent blood pressure checks, medical reviews and follow-up from community health workers were also significantly more likely to achieve meaningful improvements. 

Read the full story on the Nuffield Department of Primary Care Health Sciences website.

 

 

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience